(Q34807111)

4 August 2017

1 reference

title

Recombinant micro-genes and dystrophin viral vectors (English)

1 reference

4 August 2017

Dickson G

1

1 reference

4 August 2017

Roberts ML

series ordinal

2

1 reference

4 August 2017

Wells DJ

series ordinal

3

1 reference

4 August 2017

Fabb SA

series ordinal

4

1 reference

4 August 2017

publication date

1 October 2002

1 reference

4 August 2017

published in

Neuromuscular Disorders

1 reference

4 August 2017

volume

12 Suppl 1

1 reference

4 August 2017

page(s)

S40-4

1 reference

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Adenovirus as an expression vector in muscle cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Expression of a recombinant dystrophin in mdx mice using adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Human serum lyses RNA tumour viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

High-titer packaging cells producing recombinant retroviruses resistant to human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Genetic modification of the hematolymphoid compartment for therapeutic purposes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Construction of new retroviral producer cells from adenoviral and retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Adeno-retroviral chimeric viruses as in vivo transducing agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Chimeric viral vectors--the best of both worlds?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its potential use for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Tissue-specific isoforms of dystrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900080-9

7 January 2021

10.1016/S0960-8966(02)00080-9

Identifiers

DOI

1 reference

4 August 2017

1 reference